Daktronics CEO exercises stock options, sells shares

Daktronics Inc. President and CEO Bradley T. Wiemann reported multiple equity transactions on January 20, 2026.

Rhea-AI Filing Summary

Daktronics Inc. President and CEO Bradley T. Wiemann reported multiple equity transactions on January 20, 2026. He exercised several incentive stock options for 5,000 shares at $4.11, 2,500 shares at $5.66, 4,500 shares at $3.02, and 914 shares at $9.85, receiving an equivalent number of common shares.

He also had several transactions coded "F" in which common shares were sold at a weighted-average price of $21.43 to cover obligations related to the option exercises, as described in a sell-to-cover footnote. After these transactions, he directly held 129,945.723 shares of Daktronics common stock.

Insider Trade Summary

12,914 shares exercised/converted

Exercise 14 txns

Insider Wiemann Bradley T

Role President and CEO

Type	Security	Shares	Price	Value
Exercise	Incentive Stock Options	5,000	$4.11	$21K
Exercise	Incentive Stock Options	2,500	$5.66	$14K
Exercise	Incentive Stock Options	4,500	$3.02	$14K
Exercise	Incentive Stock Options	914	$9.85	$9K
Exercise	Common Stock	5,000	$4.11	$21K
Exercise	Common Stock	2,500	$5.66	$14K
Exercise	Common Stock	4,500	$3.02	$14K
Exercise	Common Stock	914	$9.85	$9K
Exercise Price or Tax Liability	Common Stock	730.054	$21.43	$16K
Exercise Price or Tax Liability	Common Stock	528.646	$21.43	$11K
Exercise Price or Tax Liability	Common Stock	364.413	$21.43	$8K
Exercise Price or Tax Liability	Common Stock	666.403	$21.43	$14K
Exercise Price or Tax Liability	Common Stock	693.044	$21.43	$15K
Exercise Price or Tax Liability	Common Stock	1,597.643	$21.43	$34K

Holdings After Transaction: Incentive Stock Options — 0 contracts (Direct); Common Stock — 129,945.723 shares (Direct)

Footnotes (5)

1. F1. These sales were made pursuant to a sell-to-cover transaction in which the reporting person sold shares previously acquired in multiple prior purchase periods under the Company's Employee Stock Purchase Plan ("ESPP") to cover exercise-related obligations arising from the option exercise reported herein. The price reported for each transaction is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $21.40 to $21.51.
2. F2. Incentive Stock Options 20% vested each year for a total of five years - vesting schedule 8/23/2021, 8/23/2022, 08/23/2023, 08/23/2024, 08/23/2025.
3. F3. Incentive Stock Options 20% vested each year for a total of five years - vesting schedule 08/23/2022; 08/23/2023; 08/23/2024; 08/23/2025; 08/23/2026
4. F4. Incentive Stock Options 20% vested each year for a total of five years - vesting schedule 08/23/2023, 08/23/2024, 08/23/2025, 08/23/2026, 08/23/2027.
5. F5. Incentive Stock Options vest 20% each for a total of five years - vesting schedule 08/23/2024, 08/23/2025, 08/23/2026, 08/23/2027, 08/23/2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Daktronics (DAKT) disclose for January 20, 2026?

Daktronics disclosed that President and CEO Bradley T. Wiemann exercised multiple incentive stock options and reported related common stock transactions on January 20, 2026.

How many Daktronics options did CEO Bradley Wiemann exercise in this Form 4?

Bradley Wiemann exercised incentive stock options covering 5,000 shares at $4.11, 2,500 shares at $5.66, 4,500 shares at $3.02, and 914 shares at $9.85 of Daktronics common stock.

What do the "F" transactions in the Daktronics (DAKT) Form 4 represent?

The "F" transactions are sales of Daktronics common stock made at a weighted-average price of $21.43, described as a sell-to-cover to meet exercise-related obligations from the reported option exercises.

How many Daktronics shares does the CEO own after these Form 4 transactions?

Following the reported transactions, Bradley Wiemann directly owned 129,945.723 shares of Daktronics common stock.

Were the Daktronics CEO’s share sales discretionary or sell-to-cover?

According to the footnote, the reported sales were part of a sell-to-cover transaction using shares acquired under the company’s Employee Stock Purchase Plan to cover obligations from the option exercises.

What vesting schedules applied to the Daktronics incentive stock options in this filing?

The incentive stock options generally vest 20% per year over five years, with specific vesting dates ranging from 08/23/2021 through 08/23/2028, as detailed in the filing footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/22/2026 - 02:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wiemann Bradley T

(Last) (First) (Middle)

201 DAKTRONICS DRIVE

(Street)

BROOKINGS SD 57006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DAKTRONICS INC /SD/ [ DAKT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/20/2026		M		5,000	A	$4.11	126,611.926	D
Common Stock	01/20/2026		M		2,500	A	$5.66	129,111.926	D
Common Stock	01/20/2026		M		4,500	A	$3.02	133,611.926	D
Common Stock	01/20/2026		M		914	A	$9.85	134,525.926	D
Common Stock	01/20/2026		F		730.054(1)	D	$21.43	133,795.872	D
Common Stock	01/20/2026		F		528.646(1)	D	$21.43	133,267.226	D
Common Stock	01/20/2026		F		364.413(1)	D	$21.43	132,902.813	D
Common Stock	01/20/2026		F		666.403(1)	D	$21.43	132,236.41	D
Common Stock	01/20/2026		F		693.044(1)	D	$21.43	131,543.366	D
Common Stock	01/20/2026		F		1,597.643(1)	D	$21.43	129,945.723	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Incentive Stock Options	$4.11	01/20/2026		M			5,000	(2)	09/03/2030	Common Stock	5,000	$4.11	0	D
Incentive Stock Options	$5.66	01/20/2026		M			2,500	(3)	09/02/2031	Common Stock	2,500	$5.66	0	D
Incentive Stock Options	$3.02	01/20/2026		M			4,500	(4)	09/08/2032	Common Stock	4,500	$3.02	0	D
Incentive Stock Options	$9.85	01/20/2026		M			914	(5)	09/10/2033	Common Stock	914	$9.85	0	D

Explanation of Responses:

1. These sales were made pursuant to a sell-to-cover transaction in which the reporting person sold shares previously acquired in multiple prior purchase periods under the Company's Employee Stock Purchase Plan ("ESPP") to cover exercise-related obligations arising from the option exercise reported herein. The price reported for each transaction is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $21.40 to $21.51.

2. Incentive Stock Options 20% vested each year for a total of five years - vesting schedule 8/23/2021, 8/23/2022, 08/23/2023, 08/23/2024, 08/23/2025.

3. Incentive Stock Options 20% vested each year for a total of five years - vesting schedule 08/23/2022; 08/23/2023; 08/23/2024; 08/23/2025; 08/23/2026

4. Incentive Stock Options 20% vested each year for a total of five years - vesting schedule 08/23/2023, 08/23/2024, 08/23/2025, 08/23/2026, 08/23/2027.

5. Incentive Stock Options vest 20% each for a total of five years - vesting schedule 08/23/2024, 08/23/2025, 08/23/2026, 08/23/2027, 08/23/2028.

Remarks:

	Bradley T. Wiemann	01/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.